Trump to unveil new drug price deal with Regeneron amid affordability push
Regeneron would be the 17th drug company to agree to lower its prices as part of the administration’s Most Favored Nation initiative.
Original Source
Read the full article at Washingtonpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.